Long-Term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis with Active Choroidal Neovascularization Managed with Intravitreal Bevacizumab.

MLA

Chen, San-Ni, et al. “Long-Term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis with Active Choroidal Neovascularization Managed with Intravitreal Bevacizumab.” Ocular Immunology and Inflammation, vol. 28, no. 1, 2020, pp. 33–38. EBSCOhost, https://doi.org/10.1080/09273948.2019.1588335.

APA

Chen, S.-N., Chen, Y.-L., & Yang, B. C.-L. (2020). Long-Term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis with Active Choroidal Neovascularization Managed with Intravitreal Bevacizumab. Ocular Immunology and Inflammation, 28(1), 33–38. https://doi.org/10.1080/09273948.2019.1588335

Chicago

Chen, San-Ni, Yi-Ling Chen, and Benjamin Chi-Lan Yang. 2020. “Long-Term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis with Active Choroidal Neovascularization Managed with Intravitreal Bevacizumab.” Ocular Immunology and Inflammation 28 (1): 33–38. doi:10.1080/09273948.2019.1588335.